IM Cannabis Corp. (NASDAQ:IMCC) Q4 2023 Earnings Conference Call March 28, 2024 9:00 AM ET

Company Participants

Anna Taranko - Director, Investor & Public Relations
Oren Shuster - Chief Executive Officer
Uri Birenberg - Chief Financial Officer

Conference Call Participants

Aaron Grey - Alliance Global

Operator

Good morning and welcome to IM Cannabis' Fourth Quarter 2023 and Full Year 2023 Earnings Conference Call. Today's conference call is being recorded. At this time, I would like to turn the conference over to Anna Taranko, Director of Investor and Public Relations.

Anna Taranko

Good morning and thank you operator. Joining me for today's call are IM Cannabis Chief Executive Officer, Oren Shuster; and Chief Financial Officer, Uri Birenberg.

The earnings press release that accompanies this call is available on the Investor Relations section of our website at investors.imcannabis.com. Today's call will include estimates and other forward-looking information and statements including statements concerning future results of operations, economic conditions, and anticipated courses of action and are based on assumptions, expectations, estimates, and projections as the date hereof.

This information may involve known and unknown risk, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements. Factors that could cause or contribute to such differences are described in detail in the company's most recent filings available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov.

Furthermore, certain non-IFRS measures will be referred to during this call and the term non-IFRS adjusted EBITDA loss will hereafter we referred to as adjusted EBITDA loss.

Any estimates or forward-looking information or statements provided are accurate only as of the date of this call and the company undertakes no obligation to publicly update any forward-looking information or statements or supply new information regarding the circumstances after the date of this call. Please also note that all references on this call reflect currency in Canadian dollars.

With that, I'd like to turn the call over to Oren Shuster, CEO of IM Cannabis. Oren please go ahead.

Oren Shuster

Thank you, Anna. Good morning everyone and thank you for joining us today. As you know we are a medical cannabis company based in Israel and Germany, which is why we will focus the call today on the regularization in Germany, the impact of the Israel-Hamas war, and in our Q4 results and the potential reverse-merger with Kadimastem, which we announced on February 28.